07:00 , Oct 20, 2014 |  BC Week In Review  |  Company News

ContraFect, China CDC deal

ContraFect and the center's National Institute for Viral Disease and Control (IVCD) partnered to develop preclinical compound CF-404 to treat influenza worldwide. Under the deal, which is initially for two years, ContraFect will provide CF-404...